News

Drugmaker already convinced its lenders to relax interest-coverage term in April.

Drugmaker already convinced its lenders to relax interest-coverage term in April.

New report estimates the average cost of company coverage will go up 6% next year.

New report estimates the average cost of company coverage will go up 6% next year.

Accord with 44 states resolves investigation into interest-rate manipulation.

Accord with 44 states resolves investigation into interest-rate manipulation.